Beom K. Choi

5.1k total citations
70 papers, 2.6k citations indexed

About

Beom K. Choi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Beom K. Choi has authored 70 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Immunology, 19 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Beom K. Choi's work include Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (27 papers). Beom K. Choi is often cited by papers focused on Immune Cell Function and Interaction (35 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (27 papers). Beom K. Choi collaborates with scholars based in South Korea, United States and Japan. Beom K. Choi's co-authors include Byoung S. Kwon, Dass S. Vinay, Young H. Kim, Woojin Kang, Hyeon‐Woo Lee, Su K. Seo, Byoung S. Kwon, Kyung‐Ok Nam, Hyun Hwa Kim and Su-Jung Park and has published in prestigious journals such as Circulation, Nature Medicine and Nature Communications.

In The Last Decade

Beom K. Choi

69 papers receiving 2.5k citations

Peers

Beom K. Choi
Xuguang Tai United States
Armelle Prévost‐Blondel France
Fernando Aranda Spain
Helena Harlin United States
Jason Brayer United States
Xuejun Fan United States
Mathieu Bléry France
Eszter Lázár‐Molnár United States
Timothy Back United States
Xuguang Tai United States
Beom K. Choi
Citations per year, relative to Beom K. Choi Beom K. Choi (= 1×) peers Xuguang Tai

Countries citing papers authored by Beom K. Choi

Since Specialization
Citations

This map shows the geographic impact of Beom K. Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beom K. Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beom K. Choi more than expected).

Fields of papers citing papers by Beom K. Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beom K. Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beom K. Choi. The network helps show where Beom K. Choi may publish in the future.

Co-authorship network of co-authors of Beom K. Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Beom K. Choi. A scholar is included among the top collaborators of Beom K. Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beom K. Choi. Beom K. Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Rohit Kumar, Young Ho Kim, Sang-Jin Lee, Hyeon‐Seok Eom, & Beom K. Choi. (2024). 4-1BB immunotherapy: advances and hurdles. Experimental & Molecular Medicine. 56(1). 32–39. 33 indexed citations
2.
Choi, Wonyoung, Youngjoo Lee, Beom K. Choi, et al.. (2023). Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumors. Cytotherapy. 25(11). 1236–1241. 3 indexed citations
3.
Lee, Eun‐Young, et al.. (2021). TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma. Molecules and Cells. 44(11). 784–794. 7 indexed citations
4.
Singh, Rohit Kumar & Beom K. Choi. (2021). A Transient Transfection-based Cell Adhesion Assay with 293T Cells. BIO-PROTOCOL. 11(1). e3878–e3878. 1 indexed citations
5.
Kim, Kiwan, Ho‐Shin Gwak, Nayoung Han, et al.. (2021). Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study. Frontiers in Immunology. 12. 715000–715000. 19 indexed citations
6.
Kim, Seon-Hee, Rohit Kumar Singh, Chungyong Han, et al.. (2020). Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8+ T cell responses. Cellular and Molecular Immunology. 18(8). 1956–1968. 11 indexed citations
7.
8.
Han, Chungyong, Seon-Hee Kim, Rohit Kumar Singh, et al.. (2018). Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression. Nature Communications. 9(1). 468–468. 28 indexed citations
9.
Eom, Hyeon‐Seok, Beom K. Choi, Youngjoo Lee, et al.. (2016). Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors. Journal of Immunotherapy. 39(3). 140–148. 17 indexed citations
10.
Heo, Kyun, Hyun Jung Kim, Yun Hee Kim, et al.. (2016). An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies. Journal of Controlled Release. 229. 1–9. 71 indexed citations
11.
Park, Jun Won, Beom K. Choi, Byoung S. Kwon, et al.. (2014). Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E‐cadherin. Molecular Carcinogenesis. 54(11). 1521–1527. 20 indexed citations
12.
Kim, Young H., Beom K. Choi, Ho S. Oh, et al.. (2009). Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy. Molecular Cancer Therapeutics. 8(2). 469–478. 41 indexed citations
13.
Vinay, Dass S., Chang H. Kim, Beom K. Choi, & Byoung S. Kwon. (2009). Origins and functional basis of regulatory CD11c+CD8+ T cells. European Journal of Immunology. 39(6). 1552–1563. 32 indexed citations
14.
Kim, Young H., et al.. (2008). Combination Therapy with Cisplatin and Anti–4-1BB: Synergistic Anticancer Effects and Amelioration of Cisplatin-Induced Nephrotoxicity. Cancer Research. 68(18). 7264–7269. 47 indexed citations
15.
Choi, Beom K., Young H. Kim, Woojin Kang, et al.. (2007). Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy. Cancer Research. 67(18). 8891–8899. 54 indexed citations
16.
Kim, Wonjung, Kyoungho Suk, Young Mo Kang, et al.. (2007). Reverse signaling initiated from GITRL induces NF-κB activation through ERK in the inflammatory activation of macrophages. Molecular Immunology. 45(2). 523–533. 52 indexed citations
17.
Vinay, Dass S., Jae‐Hoon Choi, Jung Dae Kim, Beom K. Choi, & Byoung S. Kwon. (2007). Role of endogenous 4‐1BB in the development of systemic lupus erythematosus. Immunology. 122(3). 394–400. 28 indexed citations
18.
Kim, Young H., Su K. Seo, Beom K. Choi, et al.. (2005). 4-1BB costimulation enhances HSV-1-specific CD8+ T cell responses by the induction of CD11c+CD8+ T cells. Cellular Immunology. 238(2). 76–86. 34 indexed citations
19.
Lee, Hyeon‐Woo, Su-Jung Park, Beom K. Choi, et al.. (2002). 4-1BB Promotes the Survival of CD8+ T Lymphocytes by Increasing Expression of Bcl-xL and Bfl-1. The Journal of Immunology. 169(9). 4882–4888. 296 indexed citations
20.
Kwon, Byoung S., Su K. Seo, Beom K. Choi, et al.. (2002). Immune Responses in 4-1BB (CD137)-Deficient Mice. The Journal of Immunology. 168(11). 5483–5490. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuguang Tai Breakdown of academic impact, for papers by Armelle Prévost‐Blondel Breakdown of academic impact, for papers by Fernando Aranda Breakdown of academic impact, for papers by Helena Harlin Breakdown of academic impact, for papers by Jason Brayer Breakdown of academic impact, for papers by Xuejun Fan Breakdown of academic impact, for papers by Mathieu Bléry Breakdown of academic impact, for papers by Eszter Lázár‐Molnár Breakdown of academic impact, for papers by Timothy Back
Rankless by CCL
2026